PT95896A - Processo para a preparacao de uma composicao de libertacao retardada para tratamento de doencas periodonticas - Google Patents

Processo para a preparacao de uma composicao de libertacao retardada para tratamento de doencas periodonticas

Info

Publication number
PT95896A
PT95896A PT95896A PT9589690A PT95896A PT 95896 A PT95896 A PT 95896A PT 95896 A PT95896 A PT 95896A PT 9589690 A PT9589690 A PT 9589690A PT 95896 A PT95896 A PT 95896A
Authority
PT
Portugal
Prior art keywords
preparation
treatment
composition
diseases
periodontic
Prior art date
Application number
PT95896A
Other languages
English (en)
Other versions
PT95896B (pt
Inventor
Nalinkant Chunilal Damani
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PT95896A publication Critical patent/PT95896A/pt
Publication of PT95896B publication Critical patent/PT95896B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT95896A 1989-11-17 1990-11-15 Processo para a preparacao de uma composicao de libertacao retardada para tratamento de doencas periodonticas PT95896B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/439,064 US5262164A (en) 1989-11-17 1989-11-17 Sustained release compositions for treating periodontal disease

Publications (2)

Publication Number Publication Date
PT95896A true PT95896A (pt) 1991-09-13
PT95896B PT95896B (pt) 1998-01-30

Family

ID=23743140

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95896A PT95896B (pt) 1989-11-17 1990-11-15 Processo para a preparacao de uma composicao de libertacao retardada para tratamento de doencas periodonticas

Country Status (14)

Country Link
US (1) US5262164A (pt)
EP (2) EP0671175A3 (pt)
JP (1) JPH03209313A (pt)
KR (1) KR0156916B1 (pt)
AT (1) ATE133858T1 (pt)
AU (1) AU648761B2 (pt)
CA (1) CA2029050C (pt)
DE (1) DE69025270T2 (pt)
DK (1) DK0429224T3 (pt)
ES (1) ES2082833T3 (pt)
FI (1) FI98124C (pt)
GR (1) GR3018933T3 (pt)
IE (1) IE72515B1 (pt)
PT (1) PT95896B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US5198220A (en) * 1989-11-17 1993-03-30 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5230895A (en) * 1990-05-01 1993-07-27 Copley Pharmaceutical Inc. Sustained released delivery system for use in the periodontal pocket
US5620700A (en) * 1990-10-30 1997-04-15 Alza Corporation Injectable drug delivery system and method
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
DE69621247T2 (de) * 1995-12-20 2002-10-24 Unilever Nv Desensibilisierungszahnpasta
GB9617001D0 (en) * 1996-08-13 1996-09-25 Tillotts Pharma Ag Oral composition
GB9618964D0 (en) * 1996-09-11 1996-10-23 Tillotts Pharma Ag Oral composition
JP2001524958A (ja) * 1997-04-17 2001-12-04 ジーエス ディベロップメント アクティエボラーグ 新規な液晶をベースとする生物接着性薬剤送出系
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
WO1999012640A1 (en) 1997-09-09 1999-03-18 Select Release, L.C. Coated particles, methods of making and using
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
BE1011899A6 (fr) 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
WO2000067708A2 (en) * 1999-05-07 2000-11-16 Board Of Regents, The University Of Texas System Oral steroidal hormone compositions and methods of use
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
AU2001278516A1 (en) * 2000-08-07 2002-02-18 Unilever Plc Oral cosmetic composition comprising petroleum jelly enrobing an active agent
US7008646B2 (en) * 2001-02-20 2006-03-07 Patrick Thomas Spicer Cubic liquid crystalline compositions and methods for their preparation
GB2381449A (en) * 2001-10-31 2003-05-07 Smithkline Beecham Plc Oral hygiene compositions comprising an electron acceptor
JP2003171301A (ja) * 2001-11-09 2003-06-20 Mahidol Univ 歯周炎治療における補助剤としてのカルメグゲル
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
US20120134936A1 (en) * 2005-03-18 2012-05-31 Lg Household & Health Care Ltd. Tooth Whitener
MX2007011464A (es) * 2005-03-18 2007-10-12 Lg Household & Health Care Ltd Blanqueador dental.
US20080219935A1 (en) * 2005-07-08 2008-09-11 Sang-Hoon Kwak Phase Transitive Breath Care Products
US8778386B2 (en) 2005-12-13 2014-07-15 Kimberly-Clark Worldwide, Inc. Anti-microbial substrates with peroxide treatment
EP2313083A1 (en) * 2008-07-22 2011-04-27 Lupin Limited Oral compositions of clindamycin
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
FI20120287A (fi) * 2011-10-26 2013-04-27 Patolab Oy Hartsihappoja sisältävä vesikoostumus käytettäväksi antimikrobisena hoitoaineena ja lisäaineena
WO2015021387A2 (en) * 2013-08-09 2015-02-12 Britt George N Formulations for control and prevention of periodontal and perimplant diseases and other diseases and conditions of the mouth, and supra and sub-gingival delivery methods and systems for such formulations
EP4100029A4 (en) 2020-02-03 2024-03-06 Curemast, Inc. COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING MASTITIS

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976251A (en) * 1957-04-19 1961-03-21 Eastman Kodak Co Glycerol fatty acid partial ester gels
US3867190A (en) * 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
US4098885A (en) * 1977-10-14 1978-07-04 Zoecon Corporation Equine anthelmintic
US4175326A (en) * 1977-10-26 1979-11-27 Forsyth Dental Infirmary For Children Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
US4219458A (en) * 1978-10-02 1980-08-26 Monsanto Company Block copolymer hot melt adhesive compositions
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4764377A (en) * 1983-10-07 1988-08-16 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
USRE33093E (en) * 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
ATE77559T1 (de) * 1986-11-14 1992-07-15 Theratech Inc Erhoehung des penetrationsvermoegens mittels eines aus die zellhuelle veraendernden substanzen und kurzkettigen alkoholen bestehenden binaeren systems.
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
DK254289D0 (da) * 1989-05-25 1989-05-25 Dumex Ltd As Middel til behandling af svampeinfektioner
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
US5084267A (en) * 1989-11-17 1992-01-28 The Procter & Gamble Company Sustained release compositions for treating periodontal disease

Also Published As

Publication number Publication date
PT95896B (pt) 1998-01-30
ATE133858T1 (de) 1996-02-15
DK0429224T3 (da) 1996-06-24
US5262164A (en) 1993-11-16
KR0156916B1 (ko) 1998-11-16
EP0429224A1 (en) 1991-05-29
CA2029050A1 (en) 1991-05-18
FI905682A0 (fi) 1990-11-16
DE69025270T2 (de) 1997-01-23
AU648761B2 (en) 1994-05-05
JPH03209313A (ja) 1991-09-12
EP0671175A2 (en) 1995-09-13
GR3018933T3 (en) 1996-05-31
CA2029050C (en) 1997-01-07
KR910009242A (ko) 1991-06-28
EP0429224B1 (en) 1996-02-07
EP0671175A3 (en) 1996-02-28
IE904149A1 (en) 1991-05-22
IE72515B1 (en) 1997-04-23
FI905682A (fi) 1991-05-18
FI98124C (fi) 1997-04-25
ES2082833T3 (es) 1996-04-01
FI98124B (fi) 1997-01-15
DE69025270D1 (de) 1996-03-21
AU6667890A (en) 1991-05-23

Similar Documents

Publication Publication Date Title
PT95896A (pt) Processo para a preparacao de uma composicao de libertacao retardada para tratamento de doencas periodonticas
FI98126B (fi) Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi
ES2099977T3 (es) Composiciones de liberacion prolongada para tratar enfermedades periodontales.
PT88200A (pt) Processo para a preparacao de uma composicao para o tratamento da pele
ES2044925T3 (es) Composiciones farmaceuticas de liberacion retardada.
ES2082834T3 (es) Composiciones con liberacion prolongada para tratar enfermedades periodontales.
DE59002748D1 (de) Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
BR9005135A (pt) Composicao para tratar ou evitar placa dental ou doencas da gengiva ou periodontais e metodo para reducao de placa ou gengivite
OA09121A (fr) Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant.
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
IT8848258A0 (it) Composizione farmaceutica per il trattamento delle affezioni parodontali
BR9501691A (pt) Derivado de ácido graxo processo para a preparação de um derivado de ácido graxo composição farmacêutica e método para a prevenção e ou tratamento de doenças humanas ou animais

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910404

FG3A Patent granted, date of granting

Effective date: 19971008

PD3A Change of proprietorship

Owner name: DUMEX-ALPHARMA APS

Effective date: 20011206

TE3A Change of address (patent)

Owner name: DUMEX-ALPHARMA A/S

Effective date: 20011206

PC3A Transfer or assignment

Free format text: 20010926 COLGATE-PALMOLIVE COMPANY US

PD3A Change of proprietorship

Owner name: ALPHARMA APS

Effective date: 20010926

MM3A Annulment or lapse

Effective date: 20060410